In this article, we present some of the phase III clinical trial failures that made major news headlines in 2019. These were compounds on which companies had bet big, with patients and the medical community having had high hopes.
from RTT - Biotech https://ift.tt/2szfrHp
via IFTTT
No comments:
Post a Comment